UroGen Pharma Ltd.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $25.7M | $122.0M | $52.9M |
| FY2021 | $111.3M | $119.7M | $44.4M |
| FY2022 | $225.0M | $135.6M | $55.4M |
| FY2023 | $243.5M | $178.3M | $95.0M |
| FY2024 | $294.5M | $285.7M | $172.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $25.7M | $122.0M | $52.9M |
| FY2021 | $111.3M | $119.7M | $44.4M |
| FY2022 | $225.0M | $135.6M | $55.4M |
| FY2023 | $243.5M | $178.3M | $95.0M |
| FY2024 | $294.5M | $285.7M | $172.0M |